Table 4 Measurements.

Kimchi et al.

1984

In-hospital all cause

Radionuclide

LVEF

(46 ± 16%)

-

RVEF

(37 ± 2%)

RVEDVI

(98 ± 10 mL/m²)

Dhainaut et al.

1988

In-hospital refractory shock

PAC-TD

-

-

RVEF

(30 ± 12%)

-

Vincent et al.

1989

In-hospital protracted sepsis

PAC-TD

-

-

RVEF

(25 ± 8%)

-

Vincent et al.

1992

In-hospital refractory shock

PAC-TD

-

-

RVEF

(38 ± 16%)

RVEDVI

(90 ± 31 mL/m²)

Jardin et al.

1999

In hospital all cause

TEE

LVEF

(49 ± 15%)

LVEDVI^a

(69 ± 24 mL/m²)

-

-

McLean et al.

2007

In hospital all cause

TTE

LVEF

(48 ± 15%)

LVEDD

(47 ± 10)

-

-

Cariou et al

2008

In hospital all cause

TEE

LVFAC

(46 ± 19%)

LVEDA

(16 ± 6 cm²)

-

-

Etchecopar-Chevreuil et al.

2008

In-hospital all cause

TEE

LVEF

(47 ± 20%)

LVEDV

(97 ± 25 mL)

-

-

Vieillard-Baron et al.

2008

28-day all cause

TEE

LVEF

(51 ± 17%)

LVEDVI^a

(63 ± 23 mL/m²)

-

-

Sturgess et al.

2010

In-hospital all cause

TTE

LVEF

(43 ± 14%)

LVEDVI^a

(67 ± 24 mL/m²)

-

-

Furian et al.

2012

In-hospital sepsis

TTE

LVEF

(57 ± 13%)

LVEDD/ht

(28 ± 3 mm/m)

-

RVD (TTE)

(24 ± 4 mm)

Landesberg et al.

2012

In-hospital all cause

TTE

LVEF

(59 ± 11%)

LVEDD

(46 ± 10 mm)

LVEDVI^a

(56 ± 18 mL/m²)

RVSV change

(7.5 ± 3.7 mL)

RVEDA

(21 ± 6 cm²)

Pulido et al.

2012

30-day all cause

TTE

LVEF

(57 ± 15%)

LVEDD

(46 ± 10 mm)

-

-

Weng et al.

2012

90-day all cause

TTE

LVEF

(55 ± 16%)

LVEDV

(72 ± 24 mL)

-

-